EUVIMEDEUVIMED entdecken
Crossref

Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies

Derya Osmaniye, Nurnehir Baltacı Bozkurt, Berkant Kurban, Gamze Benli Yardımcı, Yusuf Ozkay, Zafer Asım Kaplancıklı

Chemistry & Biodiversity · 2023-09 · 20 (9)

DOI: 10.1002/cbdv.202300944 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, online erschienen am 21.08.2023. Verfasst von Derya Osmaniye und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey. Hauptthemen laut MEDLINE: Vascular Endothelial Growth Factor Receptor-2, Imidazoles. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, 12 novel 2‐((1‐(4‐(1 H ‐imidazol‐1‐yl)phenyl)ethylidene)hydrazineylidene)‐3‐ethyl‐4‐(substitutephenyl)‐2,3‐dihydrothiazole derivatives were obtained. Among these compounds, 2‐((1‐(4‐(1 H ‐imidazol‐1‐yl)phenyl)ethylidene)hydrazineylidene)‐4‐([1,1′‐biphenyl]‐4‐yl)‐3‐ethyl‐2,3‐dihydrothiazole ( 4h ) was chosen as the most active derivative in the series. According to the MTT results, compounds 4h and 4k showed activity with IC 50 =4.566±0.246 μM and IC 50 =4.537±0.463 μM, respectively. Unlike other derivatives, compound 4h carries a phenyl ring in the 4th position of the phenyl ring. This bulky group allowed the compound to settle in the enzyme active site. Dynamic studies show that the stability of the compound does not change over 40 ns. RMSD, RMSF and Rg parameters all remained within acceptable limits. The uninterrupted aromatic hydrogen bonding of the enzyme active site with the important amino acids Cys919, Glu885 and Asp1046 proves the inhibitory potential of compound 4h on the VEGFR‐2 enzyme. It is thought that more active compounds will be reached with the derivatives to be synthesized starting from compound 4h .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Endothelial Growth Factor Receptor-2ImidazolesMolecular StructureStructure-Activity RelationshipMolecular Docking SimulationThiazoles

Stichwörter der Autor:innen

2,3-dihydrothiazoleVEGFR-2imidazolemolecular dockingmolecular dynamics

Substanzen

Vascular Endothelial Growth Factor Receptor-2Imidazoles2,3-dihydrothiazoleThiazoles

Autor:innen und Institutionen

  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey.
  • Central Analysis Laboratory, Faculty of Pharmacy, Anadolu University, 26470, Eskişehir, Turkey.
  • Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, 03030, Afyonkarahisar, Turkey.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, 03030, Afyonkarahisar, Turkey.

Zitieren

APA

Osmaniye, D., Bozkurt, N. B., Kurban, B., Yardımcı, G. B., Ozkay, Y., & Kaplancıklı, Z. A. (2023). Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies. Chemistry & Biodiversity, 20(9). https://doi.org/10.1002/cbdv.202300944

Vancouver

Osmaniye D, Bozkurt NB, Kurban B, Yardımcı GB, Ozkay Y, Kaplancıklı ZA. Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies. Chemistry & Biodiversity. 2023;20(9). doi:10.1002/cbdv.202300944

BibTeX
@article{Osmaniye2023,
  author = {Osmaniye, Derya and Bozkurt, Nurnehir Baltacı and Kurban, Berkant and Yardımcı, Gamze Benli and Ozkay, Yusuf and Kaplancıklı, Zafer Asım},
  title = {Synthesis of Imidazole‐2,3‐dihydrothiazole Compounds as VEGFR‐2 Inhibitors and Their Support with in Silico Studies},
  journal = {Chemistry & Biodiversity},
  year = {2023},
  volume = {20},
  number = {9},
  doi = {10.1002/cbdv.202300944}
}
Kostenlos starten →